"低点":关于低ER和低HER2乳腺癌的最新情况
Nicola Fusco1, Giuseppe Viale2
1Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Breast (Edinburgh, Scotland)
|November 1, 2024
概括
低ER和低HER2的乳腺癌是重要的亚型. 准确的识别和标准化测试对于开发量身定制的治疗方法和改善患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 基因组学就是基因组学.
背景情况:
- 低ER和低HER2的乳腺癌存在独特的临床挑战.
- 这些亚型表现出不同的生物行为和治疗反应.
- 传统的诊断类别并不完全涵盖这些新兴的乳腺癌亚型.
研究的目的:
- 审查有关低ER和低HER2乳腺癌的当前知识.
- 突出识别和诊断方法的挑战.
- 讨论对治疗和未来临床管理的影响.
主要方法:
- 关于ER低和HER2低乳腺癌的最新研究的文献综述.
- 对测试一致性进行实验室间评估的分析.
- 巩固有关诊断标准和治疗策略的知识.
主要成果:
- 低HER2的乳腺癌 (IHC 1-2+,没有基因放大) 显示了与特拉斯图祖马布德鲁克斯坦 (T-DXd) 的疗效.
- 低ER的乳腺癌 (1-10%的ER表达) 在内分泌治疗反应方面存在挑战.
- 不一致的测试方法使准确的亚型识别变得复杂.
结论:
- 标准化诊断方法和可重复测试对于低ER和低HER2的乳腺癌至关重要.
- 个性化治疗决策对于优化患者的治疗结果至关重要.
- 需要进一步的研究和合作来完善诊断标准和开发量身定制的治疗方法.
更多相关视频
08:29Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
82
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.6K
相关概念视频
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K